| UniProt ID | FRIL_HUMAN | |
|---|---|---|
| UniProt AC | P02792 | |
| Protein Name | Ferritin light chain | |
| Gene Name | FTL | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 175 | |
| Subcellular Localization | ||
| Protein Description | Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. Also plays a role in delivery of iron to cells. Mediates iron uptake in capsule cells of the developing kidney (By similarity).. | |
| Protein Sequence | MSSQIRQNYSTDVEAAVNSLVNLYLQASYTYLSLGFYFDRDDVALEGVSHFFRELAEEKREGYERLLKMQNQRGGRALFQDIKKPAEDEWGKTPDAMKAAMALEKKLNQALLDLHALGSARTDPHLCDFLETHFLDEEVKLIKKMGDHLTNLHRLGGPEAGLGEYLFERLTLKHD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MSSQIRQNY ------CCHHHHHHC | 30.83 | 6653779 | |
| 3 | Phosphorylation | -----MSSQIRQNYS -----CCHHHHHHCH | 28.47 | 24719451 | |
| 59 | Ubiquitination | FRELAEEKREGYERL HHHHHHHHHHHHHHH | 47.45 | - | |
| 68 | Ubiquitination | EGYERLLKMQNQRGG HHHHHHHHHHHHHCC | 42.93 | 21906983 | |
| 83 | Ubiquitination | RALFQDIKKPAEDEW HHCHHHCCCCCCCCC | 62.08 | 83 | |
| 84 | Ubiquitination | ALFQDIKKPAEDEWG HCHHHCCCCCCCCCC | 50.20 | 21906983 | |
| 92 | Ubiquitination | PAEDEWGKTPDAMKA CCCCCCCCCHHHHHH | 58.94 | 21906983 | |
| 98 | Acetylation | GKTPDAMKAAMALEK CCCHHHHHHHHHHHH | 34.41 | 19608861 | |
| 98 | Ubiquitination | GKTPDAMKAAMALEK CCCHHHHHHHHHHHH | 34.41 | 19608861 | |
| 105 | Ubiquitination | KAAMALEKKLNQALL HHHHHHHHHHHHHHH | 64.51 | 21906983 | |
| 106 | Ubiquitination | AAMALEKKLNQALLD HHHHHHHHHHHHHHH | 43.21 | - | |
| 106 | Malonylation | AAMALEKKLNQALLD HHHHHHHHHHHHHHH | 43.21 | 26320211 | |
| 119 | Phosphorylation | LDLHALGSARTDPHL HHHHHHCCCCCCHHH | 18.54 | - | |
| 127 | S-nitrosylation | ARTDPHLCDFLETHF CCCCHHHHHHHHHHC | 2.94 | 22178444 | |
| 140 | Ubiquitination | HFLDEEVKLIKKMGD HCCHHHHHHHHHHHH | 48.01 | - | |
| 144 | Ubiquitination | EEVKLIKKMGDHLTN HHHHHHHHHHHHHHH | 40.91 | - | |
| 150 | Phosphorylation | KKMGDHLTNLHRLGG HHHHHHHHHHHHCCC | 32.11 | 20068231 | |
| 165 | Phosphorylation | PEAGLGEYLFERLTL CCCCHHHHHHHHHHC | 18.20 | 22817900 | |
| 173 | Acetylation | LFERLTLKHD----- HHHHHHCCCC----- | 40.26 | 27178108 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FRIL_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FRIL_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FRIL_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| FRIL_HUMAN | FTL | physical | 16189514 | |
| M3K12_HUMAN | MAP3K12 | physical | 16169070 | |
| TAF10_HUMAN | TAF10 | physical | 16169070 | |
| FRIH_HUMAN | FTH1 | physical | 16169070 | |
| PTN_HUMAN | PTN | physical | 16169070 | |
| FRIL_HUMAN | FTL | physical | 16169070 | |
| FRIL_HUMAN | FTL | physical | 20159981 | |
| TOX4_HUMAN | TOX4 | physical | 22939629 | |
| RPB4_HUMAN | POLR2D | physical | 22939629 | |
| IF4G1_HUMAN | EIF4G1 | physical | 22939629 | |
| NAMPT_HUMAN | NAMPT | physical | 18486613 | |
| C43BP_HUMAN | COL4A3BP | physical | 22863883 | |
| PACN2_HUMAN | PACSIN2 | physical | 22863883 | |
| FRIL_HUMAN | FTL | physical | 25416956 | |
| IMA4_HUMAN | KPNA3 | physical | 25416956 | |
| MYOG_HUMAN | MYOG | physical | 25416956 | |
| SDCB1_HUMAN | SDCBP | physical | 25416956 | |
| USBP1_HUMAN | USHBP1 | physical | 25416956 |
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| 600886 | Hereditary hyperferritinemia-cataract syndrome (HHCS) |
| 606159 | Neurodegeneration with brain iron accumulation 3 (NBIA3) |
| 615604 | L-ferritin deficiency (LFTD) |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB00893 | Iron Dextran |
loading...
| Acetylation | |
| Reference | PubMed |
| "The amino acid sequence of human liver apoferritin."; Addison J.M., Fitton J.E., Lewis W.G., May K., Harrison P.M.; FEBS Lett. 164:139-144(1983). Cited for: PROTEIN SEQUENCE OF 2-36 AND 41-175. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-98, AND MASS SPECTROMETRY. | |